Literature DB >> 11836805

To the editor: Is it safe to administer a continuous infusion of ceftazidime (Fortum) prepared for 24 hours in cystic fibrosis (CF) patients?

Jean-Claude Plasse, Claire Chabloz, Annick Terrier, Gabriel Bellon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836805     DOI: 10.1002/ppul.10051

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


× No keyword cloud information.
  4 in total

Review 1.  Systematic review of stability data pertaining to selected antibiotics used for extended infusions in outpatient parenteral antimicrobial therapy (OPAT) at standard room temperature and in warmer climates.

Authors:  Stephen John Perks; Cassie Lanskey; Niechole Robinson; Tilley Pain; Richard Franklin
Journal:  Eur J Hosp Pharm       Date:  2019-06-20

2.  Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.

Authors:  William A Prescott; Allison E Gentile; Jerod L Nagel; Rebecca S Pettit
Journal:  P T       Date:  2011-11

3.  How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?

Authors:  P Bourget; A Amin; C Dupont; M Abely; N Desmazes-Dufeu; J C Dubus; B-L Jouani; C Merlette; R Nové-Josserand; J Pages; R Panzo; F Vidal; F Voge; D Hubert
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis.

Authors:  Dominique Hubert; Evelyne Le Roux; Thibaud Lavrut; Benoit Wallaert; Philippe Scheid; Dominique Manach; Dominique Grenet; Isabelle Sermet-Gaudelus; Sophie Ramel; Claire Cracowski; Anne Sardet; Nathalie Wizla; Eric Deneuville; Rodolphe Garraffo
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.